When I started my intern year, that is my first year of training in medical residency, I noticed something peculiar about the epidemiology of disease in our hospital. The Black patients on the medical wards would often present with the morbidity of their diseases almost ten to twenty years earlier than their white counterparts. A Black person with leg swelling and shortness of breath who presented with advanced heart failure …
Read more…
Uncovering the truth about racial health inequities in America: a book review
As researchers and physicians race to investigate innovative therapeutics against the novel SARS-CoV-2 virus, unanswered questions remain regarding the ethics and design of clinical trials. Namely, what is the most ethically and scientifically rigorous approach to test unproven novel or repurposed therapeutic agents during a major public health emergency? Canonically, randomized controlled trials (RCTs) have represented the gold standard for evidence-based medicine. In this approach, the efficacy of an intervention …
Read more…
An ethical approach for clinical trials during the COVID-19 pandemic
Following on the heels of The Creative Destruction of Medicine and The Patient Will See You Now, Dr. Eric Topol has published his newest book, Deep Medicine, earlier this year. While the first two books highlight how technological disruption will first digitize and then democratize medicine, his newest is about deep learning, and how artificial intelligence (AI) has the potential to ultimately deepen the patient-physician bond. It …
Read more…
A medical student reviews Eric Topol’s Deep Medicine
